Subscribe free

Metabolic and Bariatric Surgery ·

Bariatric surgery significantly reduces cancer risk in obese patients

A systematic review and meta-analysis of 21 studies revealed that metabolic and bariatric surgeries (MBS) substantially lower cancer risk in obese patients compared to non-surgical treatments. Specifically, MBS showed protective effects against colorectal (mean effect size -.28), uterine (mean effect size -.42), breast (mean effect size -.37), and esophageal cancers (mean effect size -.23). Overall, the research highlights MBS as a crucial intervention not only for obesity management but also for reducing malignancy risks.

Journal Article by Madar LO, Goldberg N (…) Perry ZH et 4 al. in Surg Obes Relat Dis

Copyright © 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

read the whole article in Surg Obes Relat Dis

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →